Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Caroline McGuinty"'
Autor:
Pietro Di Santo, Rebecca Mathew, Richard G. Jung, Trevor Simard, Stephanie Skanes, Brennan Mao, F. Daniel Ramirez, Jeffrey A. Marbach, Omar Abdel-Razek, Pouya Motazedian, Simon Parlow, Kevin E. Boczar, Gianni D’Egidio, Steven Hawken, Jordan Bernick, George A. Wells, Alexander Dick, Derek Y. So, Christopher Glover, Juan J. Russo, Caroline McGuinty, Benjamin Hibbert, the CAPITAL DOREMI investigators
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Abstract Background Cardiogenic shock (CS) is associated with significant morbidity and mortality. The impact of beta-blocker (BB) use on patients who develop CS remains unknown. We sought to evaluate the clinical outcomes and hemodynamic response pr
Externí odkaz:
https://doaj.org/article/892e9e082cce43ada4fdb355610c6730
Autor:
Kathryn Bezzina, Christophe A. Fehlmann, Ming Hao Guo, Sarah M. Visintini, Fraser D. Rubens, George A. Wells, Rosetta Mazzola, Caroline McGuinty, Allen Huang, Lara Khoury, Kevin Emery Boczar
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Background Frailty has emerged as an important prognostic marker of adverse outcomes after cardiac surgery, but evidence regarding its ability to predict quality of life after cardiac surgery is currently lacking. Whether frail patients derive the sa
Externí odkaz:
https://doaj.org/article/224bdb3306af426f82574c414c8cc402
Autor:
Natasha Aleksova, Chun‐Po S. Fan, Farid Foroutan, Yas Moayedi, Juan Duero Posada, Caroline McGuinty, Adriana Luk, Josef Stehlik, Heather J. Ross, Ana C. Alba
Publikováno v:
Clinical Transplantation. 36
Predicted heart mass (PHM) was neither derived nor evaluated in an obese population. Our objective was to evaluate size mismatch using actual body weight or ideal body weight (IBW)-adjusted PHM on mortality and risk assessment.We conducted a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a31ad308946482c87ff2a4fdc0452c3
https://doi.org/10.1111/ctr.14744
https://doi.org/10.1111/ctr.14744
Publikováno v:
Canadian Journal of Cardiology. 37:665-668
Despite advances in treatment options, heart failure (HF) remains a progressive, symptomatic, and terminal disease for a large number of patients. The need for enhanced discussions regarding prognosis and goals of care has been recognised by multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0217a4ad48c8154a77cd9d6e226bd0
https://doi.org/10.1016/j.cjca.2020.11.019
https://doi.org/10.1016/j.cjca.2020.11.019
Autor:
Filio Billia, Natasha Aleksova, Omid Kiamanesh, Heather J. Ross, Vivek Rao, Chun-Po Steve Fan, Faizan Amin, Juan Duero Posada, Caroline McGuinty, Ana C. Alba, Hanna Lee
Publikováno v:
Canadian Journal of Cardiology. 37:467-475
Background As patients with advanced heart failure are living longer, defining the impact of left ventricular assist devices (LVADs) on outcomes in an aging population is of great importance. We describe overall survival, rates of adverse events (AEs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f4b51db5a78760425e2ce359b000171
https://doi.org/10.1016/j.cjca.2020.06.010
https://doi.org/10.1016/j.cjca.2020.06.010
Autor:
Simon Parlow, Omar Abdel-Razek, Derek So, Rebecca Mathew, Jordan Bernick, Christopher Glover, Juan J Russo, George A. Wells, Pouya Motazedian, Richard G. Jung, Kevin E. Boczar, Steven Hawken, Pietro Di Santo, Benjamin Hibbert, Stephanie Skanes, Alexander Dick, Gianni D’Egidio, F. Daniel Ramirez, Caroline McGuinty, Brennan Mao, Jeffrey A. Marbach, Trevor Simard, Capital Doremi investigators
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Critical Care
Critical Care
Background Cardiogenic shock (CS) is associated with significant morbidity and mortality. The impact of beta-blocker (BB) use on patients who develop CS remains unknown. We sought to evaluate the clinical outcomes and hemodynamic response profiles in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3175f13aa2868d515e635a977d58c1cd
https://doi.org/10.1186/s13054-021-03706-2
https://doi.org/10.1186/s13054-021-03706-2
Autor:
Kathryn Bezzina, Christophe A. Fehlmann, Ming Hao Guo, Sarah M. Visintini, Fraser D. Rubens, George A. Wells, Rosetta Mazzola, Caroline McGuinty, Allen Huang, Lara Khoury, Kevin Emery Boczar
Publikováno v:
PLoS ONE
PLoS ONE, Vol 17, Iss 2 (2022)
PLoS ONE, Vol 17, Iss 2, p e0262742 (2022)
PLoS ONE, Vol 17, Iss 2 (2022)
PLoS ONE, Vol 17, Iss 2, p e0262742 (2022)
Background Frailty has emerged as an important prognostic marker of adverse outcomes after cardiac surgery, but evidence regarding its ability to predict quality of life after cardiac surgery is currently lacking. Whether frail patients derive the sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca62b8ddf8526c52b180c8288c953f20
https://pubmed.ncbi.nlm.nih.gov/35120151
https://pubmed.ncbi.nlm.nih.gov/35120151
Autor:
Aisling Kinsella, Abdullah Malik, Natasha Aleksova, Troy Francis, Eddy Fan, Valeria E. Rac, Ana C. Alba, Alice Zhu, Kimberley Lau, Julie K K Vishram-Nielsen, Aleksandra Stanimirovic, Tayler A. Buchan, Caroline McGuinty, Farid Foroutan, Juglans Alvarez, Kathryn Elizabeth Clark, Filio Billia, Heather J. Ross, Vivek Rao
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 40(4)
BACKGROUND Venoarterial extracorporeal membrane oxygenation (VA ECMO) is associated with variable outcomes. In this meta-analysis, we evaluated the mortality after VA ECMO across multiple etiologies of cardiogenic shock (CS). METHODS In June 2019, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c243c555bd6a9e72e253d11113b6b10f
https://pubmed.ncbi.nlm.nih.gov/33551227
https://pubmed.ncbi.nlm.nih.gov/33551227
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:847-848
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ede57c3fc5c507278000806867e667e5
https://doi.org/10.1016/j.healun.2020.01.1346
https://doi.org/10.1016/j.healun.2020.01.1346
Autor:
Andrea Weiss, Caroline McGuinty, Ebru Kaya, Heather J. Ross, Filio Billia, Kirsten Wentlandt, Jane MacIver, Lindsay Hurlburt, Derek Leong
Publikováno v:
Journal of pain and symptom management. 59(5)
Despite significant advances in heart failure (HF) treatment, HF remains a progressive, extremely symptomatic, and terminal disease with a median survival of 2.1 years after diagnosis. HF often leads to a constellation of symptoms, including dyspnea,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733d2da252ea32900c9e86bfbd640389
https://pubmed.ncbi.nlm.nih.gov/31866489
https://pubmed.ncbi.nlm.nih.gov/31866489